Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. Fluticasone Propionate and Salmeterol inhalation powder, for oral inhalation useInitial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) is indicated for the treatment of asthma in adult and pediatric patients aged 12 years and older. Fluticasone Propionate/Salmeterol MDPI should be used for patients not adequately controlled on a long term asthma control medication such as an inhaled corticosteroid or whose disease warrants initiation of treatment with both an inhaled corticosteroid and long acting beta2-adrenergic agonist (LABA). Limitations of Use: Fluticasone Propionate/Salmeterol MDPI is not indicated for the relief of acute bronchospasm.
- generic_name
- fluticasone propionate and salmeterol
- product_names
- Fluticasone Propionate and Salmeterol
- ndc
- 50090-3271, 50090-3272, 50090-3387, 0093-3608, 50090-3271-0, 0093-3607, 50090-3272-0, 0093-3609, 50090-3387-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en